Standout Papers

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody i... 1996 2026 2006 2016 1.1k
  1. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. (1996)
    José Baselga, Debu Tripathy et al. Journal of Clinical Oncology

Immediate Impact

7 by Nobel laureates 11 from Science/Nature 86 standout
Sub-graph 1 of 19

Citing Papers

Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
2021 Standout
Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
2021 Standout
3 intermediate papers

Works of J. Moore being referenced

A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily
1996

Author Peers

Author Last Decade Papers Cites
J. Moore 1356 381 257 901 803 24 2.3k
Maarten L. Janmaat 1233 550 516 699 1017 28 2.4k
V R Zurawski 905 770 296 876 1539 26 4.3k
Peter Nollau 807 391 152 532 1195 47 2.5k
M J Glennie 575 764 172 864 848 25 2.2k
Enrica Balza 881 718 185 1038 1409 55 3.1k
Emilian Racila 824 702 308 433 422 44 2.0k
Rishi Surana 1752 837 396 618 1258 24 3.3k
S. V. Litvinov 971 625 233 644 1326 28 2.4k
Robert J. Melder 635 607 333 326 932 50 2.9k
Vincent R. Zurawski 535 672 215 757 1003 44 3.2k

All Works

Loading papers...

Rankless by CCL
2026